Positive regulation of the antioxidant NRF2-ARE axis provides protection to tumor cells against oxidative damage, and thereby stimulates tumor progression by increasing the aggressiveness and chemoresistance of tumor cells [176]. The gene discussed is NFE2L2; the disease is neoplasm.